A guided path back to work after blood cancer: a trial tests the impact

NCT ID NCT06262789

Recruiting now Symptom relief Sponsor: University Hospital, Angers Source: ClinicalTrials.gov ↗

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This trial tests whether a dedicated 'return-to-work after cancer' consultation can help people who have been treated for blood cancers like leukemia, lymphoma, or multiple myeloma get back to their jobs. The consultation, led by an occupational health specialist with possible support from a psychologist, nurse, or social worker, aims to identify obstacles and guide patients through the return-to-work process. The study includes adults aged 18 to 55 who have completed their main chemotherapy and have not yet returned to work. The main goal is to see if this early support increases the percentage of patients who return to work within a year, potentially improving their quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: A specialized 'return-to-work after cancer' consultation led by an occupational health specialist, with possible support from a psychologist, nurse, or social worker.
What this could lead to: If effective, this consultation could become a standard support service to help blood cancer survivors successfully return to work, improving their financial stability, social connections, and self-esteem.
What could go wrong: This is a relatively small, early-stage trial, and the benefit of the consultation may be limited by individual circumstances, workplace factors, or the severity of the cancer and its treatment. The outcome depends on many personal and occupational variables.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

leukemia lymphoma plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LEUKEMIA LYMPHOMA MULTIPLE MYELOMA

Contacts and locations

Locations

Angers University hospital
RECRUITING

Angers, France
Brest University Hospital, Morvan Site
RECRUITING

Brest, France
Caen University hospital
NOT_YET_RECRUITING

Caen, France
Centre Henri Becquerel
RECRUITING

Rouen, France
Le Havre Hospital Group
NOT_YET_RECRUITING

Montivilliers, France
Pays de Morlaix Hospital
NOT_YET_RECRUITING

Morlaix, France
Rennes University Hospital, Pontchaillou site
NOT_YET_RECRUITING

Rennes, France
Rouen University Hospital
NOT_YET_RECRUITING

Rouen, France
Tours University Hospital, Bretonneau Site
RECRUITING

Tours, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.